Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP556622.RA5FbzKDBzF37C5reoIguV9XMOnLArNCyuoCoyxMbc8cE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP556622.RA5FbzKDBzF37C5reoIguV9XMOnLArNCyuoCoyxMbc8cE130_assertion type Assertion NP556622.RA5FbzKDBzF37C5reoIguV9XMOnLArNCyuoCoyxMbc8cE130_head.
- NP556622.RA5FbzKDBzF37C5reoIguV9XMOnLArNCyuoCoyxMbc8cE130_assertion description "[Treatment of human ACHN renal cell carcinoma (RCC) and A375 melanoma cells with the DNA demethylating nucleoside analog 5-AZA-2'-deoxycytidine (5-AZA-dC) synergistically augmented antiproliferative effects of IFN- alpha (alpha) 2 and IFN-beta (beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP556622.RA5FbzKDBzF37C5reoIguV9XMOnLArNCyuoCoyxMbc8cE130_provenance.
- NP556622.RA5FbzKDBzF37C5reoIguV9XMOnLArNCyuoCoyxMbc8cE130_assertion evidence source_evidence_literature NP556622.RA5FbzKDBzF37C5reoIguV9XMOnLArNCyuoCoyxMbc8cE130_provenance.
- NP556622.RA5FbzKDBzF37C5reoIguV9XMOnLArNCyuoCoyxMbc8cE130_assertion SIO_000772 16801630 NP556622.RA5FbzKDBzF37C5reoIguV9XMOnLArNCyuoCoyxMbc8cE130_provenance.
- NP556622.RA5FbzKDBzF37C5reoIguV9XMOnLArNCyuoCoyxMbc8cE130_assertion wasDerivedFrom befree-2016 NP556622.RA5FbzKDBzF37C5reoIguV9XMOnLArNCyuoCoyxMbc8cE130_provenance.
- NP556622.RA5FbzKDBzF37C5reoIguV9XMOnLArNCyuoCoyxMbc8cE130_assertion wasGeneratedBy ECO_0000203 NP556622.RA5FbzKDBzF37C5reoIguV9XMOnLArNCyuoCoyxMbc8cE130_provenance.